Treatment of HER2-overexpressing breast cancer
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/21/suppl_7/vii36/19446873/mdq421.pdf
Reference35 articles.
1. Novel anticancer targets: revisiting ERBB2 and discovering ERBB3;Baselga;Nat Rev Cancer,2009
2. An open-and-shut case? Recent insights into the activation of EGF/ErbB receptors;Burgess;Mol Cell,2003
3. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene;Slamon;Science,1987
4. Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer;Baselga;J Clin Oncol,1996
Cited by 94 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Prognostic value of baseline neutrophil/lymphocyte ratio in HER2-positive metastatic breast cancer: exploratory analysis of data from the CLEOPATRA trial;Breast Cancer Research;2024-01-11
2. Hormone, Targeted, and Combinational Therapies for Breast Cancers: From Humans to Dogs;International Journal of Molecular Sciences;2024-01-05
3. Advanced renal pelvis carcinoma patient with an ERBB2 insertion mutation: a case report;Journal of International Medical Research;2023-11
4. Appraisal of Systemic Treatment Strategies in Early HER2-Positive Breast Cancer—A Literature Review;Cancers;2023-08-30
5. Emerging evidence and treatment paradigm of non-small cell lung cancer;Journal of Hematology & Oncology;2023-04-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3